We report a recently observed case of primary umbilical endometriosis without previous pelvic surgery. A 41-year-old Japanese woman complained of umbilical nodular tumor. Histopathology revealed endometriosis of an approximate 10 mm resected mass. The stromal cells in endometriosis were immunohistochemically positive for CD10. Two months later the first umbilical surgery, she underwent a left salpingo-oophorectomy and release of adhesion around the left adnexa under a laparoscope. She was treated with dienogest (2 mg/day) for six months after four injections of GnRH analogue for four months. After three years of the follow-up, there were no signs of local relapse and no clinical and ultrasonographic abnormalities due to endometriosis.
Introduction
Endometriosis is defined as the presence of endometrial glands and stroma abnormal located outside the uterine cavity. It is a benign gynecological disorder affecting 10% -15% of all women of reproductive age and presents an important cause of infertility [1] [2] . Common locations of endometriosis are pelvic organs, mostly the ovaries, fallopian tubes, utero-sacral ligaments, recto-vaginal septum and pelvic peritoneum. Although the different theories have been postulated to elucidate the pathogenesis of the endometriosis, none of them has been proven to be completely exhaustive to date [3] [4] . Clinical manifestations show the pelvic pain arising around menstration, menhorrage, painful intercourse, intestinal and urinary complaints [4] [5] .
Extra-pelvic endometriosis has been described in almost every organ (i.e. gastro-intestinal organ, skin, diaphragm, lung and brain) [2] - [5] . Umbilical endometriosis (UE) is also known as Villar's nodule, named after the physician who first described the disease in 1886 [6] . While UE usually occurs secondary to surgical scars [7] [8], primary UE is extremely rare [4] [6] [9] [10] . We report here our recently observed case of UE without a previous surgery.
Clinical Case
A 41-year-old Japanese woman, gravida 1 para 1, visited to the Department of surgery of our hospital complaining of umbilical nodule for 6 months. The nodule had slowly increased in size and she noticed abdominal pain during the menstrual period. Her medical history was unremarkable without slight dysmenorrhea. She did not take any oral contraceptives and had regular menstrual cycles. Physical examination revealed a brown nodule of approximate 1 cm in diameter located deep in the umbilical fold. An ultrasound confirmed the presence of a hypo-echonic mass of 10 mm in the umbilicus. A reconstructed sagittal CT examination showed an umbilical nodular mass (Figure 1) . Under the working diagnosis of the umbilical subcutaneous tumor, the tumor was excised with saving the navel, under local anesthesia with Xylocine (lidocaine HCl, Astrazeneca, Osaka, Japan). The lesion was entirely excised deep to the fascia. There was no evidence of connection the peritoneal cavity. The tumor was measured approximate 1.0 cm in diameter (Figure 2) . The tumor was cut in longitudinally and the cut-surface of the tumor was whitish grey. The cut specimens were fixed in 10% buffered formalin (Nacalai Tesque Co. Ltd., Kyoto, Japan) for 3 days and embedded in paraffin (Wako pure chemical, Osaka, Japan). Four μm-thick sections were made and stained with hematoxylin and eosin (Muto pure chemical Co. ltd, Tokyo, Japan) for histoipathological examination. On microscopic examination, glands with stromal cells were found. To determine the presence of endometrial stroma cells, CD10 immunohistochemistry was performed using an antibody against CD10 (Novacastra, Leica Biosystem, Newcastle, UK). The stromal cells expressed cytoplasmic positivity for CD10 (Figure 3) . Thus, our pathological diagnosis was made as primary UE. The patient was informed the risk of recurrence at the time of leaving hospital. Although postoperative recovery was uneventful, she had noticed slight dysmenorrheal two weeks after the umbilical surgery. Based on the findings of CT and ultrasonography, we suspected endometriotic cyst and pelvic endometriosis. Two months later the first umbilical surgery, she underwent left salpingo-oophorectomy and release of adhesion around the left adnexa under a laparoscope. During the laparoscopic surgery, the endometriotic findings could not be observed in the peritoneum around the back side of umbilicus. The pathological diagnosis was made as ovarian cyst and pelvic peritoneal endometriosis. The second postoperative recovery was also uneventful. She was treated with dienogest (2 mg/day) for six months after four injections of GnRH analogue (Leuprorelin acetate, 1.88 mg) for four months. After three years of the follow-up, there were no signs of local relapses and no other clinical and ultrasonographic abnormalities suggesting endometriosis.
Discussion
UE has been reported to be 0.4% -4% of all patients with endometriosis and accounts for 30% -40% cases of cutaneous endometriosis [4] . The occurrence of secondary UE can be explained by iatrogenic dissemination of endometrial cells during either laparoscopic or surgical procedures [4] . It is difficult to clarify the origin of primary UE. Different hypotheses have been proposed, such as the embryonic rest theory of Wollfian or Müllerian remnants, the transplantation theory in which the ectopic endometrial tissue harbors from retrograde menstruation or hematogenous/lymphatic dissemination, or a combination of them [3] - [5] . In the present case, endometrial tissues were not observed in the peritoneum around the back side of umbilicus during the laparoscopic surgery. Thus, the embryonic rest theory or hematogenous/lymphatic dissemination is attractive for our case.
Patients with UE are commonly in the reproductive age. Victory et al. reported that the mean age was 37.7 years, with the youngest being 23 years [3] . The typical symptoms are cyclical swelling, pain and bleeding from the umbilicus concomitant with menstrual bleeding [3] [11] . There were a few UE cases without umbilical bleeding, as in our case [9] [10] .
Surgical excision of UE is recommended with wide and healthy margin [6] in order to make accurate histopathological diagnosis and exclusion of malignancy [12] [13] . The size of UE was reported to be 2.99 ± 0.20 cm (0.5 to 3 cm) [4] . Since the size (1 cm) of our UE was small, total umbilical excision was not be necessary [6] and we could preserve her navel without recurrence for three years.
Definitive treatment of UE is surgical excision and subsequent gynecological evaluation for pelvic endometriosis is recommended for all UE patients. Approximate 15% of UE patients have co-existence with pelvic endometriosis [14] . In this case, our diagnosis and treatment of UE could find symptomatic pelvic endometriosis.
When UE is coexistent with pelvic endometriosis, progesterone and GnRH analogue is useful for treatment of the symptoms and recurrence [2] - [4] . For the prevention of recurrence, the present patient was treated with dienogest and GnRH analogue after the surgical treatment. In case of local excision, UE patients should also be fully informed about the risk of recurrence [3] .
High historical risk factors of UE are reported to be previous surgery and time to presentation [4] . To avoid iatrogenic seeding to the umbilicus, a careful endometriotic excision and a laparoscopic trocar with use of a specimen bag are considered to be important [15] . There is a reported case of an endometriosis with malignant transformation in 73-year-old patient with a history of umbilical bleeding from the age of 30 until menopause [16] . No treatment for a long time might lead malignant transformed. Early surgical treatment also may induce narrow excision.
Conclusion
Although primary UE is extremely rare, UE should be suspected in case of umbilical nodule even in the absence of pelvic endometriosis or previous abdominal surgery. Definitive diagnosis of UE is made by histopathology with immunohistochemistry of CD-10. Since early diagnosis of UE can preserve the navel, surgery is the main treatment for UE. Patients should be counselled about the risk of local recurrence.
